USE THIS REPORT TO:
- Identify key areas that will change in the pharmaceutical market structure over the next five years.
- Support internal planning and decision-making with an external perspective founded on detailed analysis and transparent market forecasts.
- Understand how the market and regulatory environment could change
Remember URCH Publishing's healthcare management reports are designed to help business executives make properly informed and timely business decisions.
Chapter 1: Introduction to European Pharmaceutical Distribution
The pharmaceutical supply chain
Pharmaceutical manufacturers in the EU
The European Federation of Pharmaceutical Industry Associations (EFPIA)
European Biopharmaceutical Enterprises (EBE)
European Vaccine Manufacturers (EVM)
Pharmacies in the EU
The Pharmaceutical Group of the European Union (PGEU)
Wholesalers in the EU
Groupement International de la Répartition Pharmaceutique (GIRP)
The hospital sector
History of the pharmaceutical supply chain
Dynamics in the supply chain
Relationships within the supply chain
New changes in the supply change
Outlook for the supply chain
Case study: tax-efficient supply chain management
Global perspectives for European pharmaceutical distribution
Case study: consolidation among US pharmaceutical wholesalers
Case study: US wholesalers poised to enter Europe
Case study: US analysis of the DTP model
European status of the supply chain
European market harmonisation and pharmaceutical distribution
The politics of EU healthcare
History of the
Copyright©2010 PR Newswire.
All rights reserved